eIF3 interactions with miRNAs involved in translational control of early T cell activation
RNA-seq (gene expression) · human · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 18 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE328211_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1454361 and SRA study SRP692369. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 6 replicated groups read from 18 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9675048 WT_0h_rep1 WT_0h
- GSM9675049 WT_0h_rep2 WT_0h
- GSM9675050 WT_0h_rep3 WT_0h
- GSM9675051 KO_Clone1_0h_rep1 KO_Clone1_0h
- GSM9675052 KO_Clone1_0h_rep2 KO_Clone1_0h
- GSM9675053 KO_Clone1_0h_rep3 KO_Clone1_0h
- GSM9675054 KO_Clone2_0h_rep1 KO_Clone2_0h
- GSM9675055 KO_Clone2_0h_rep2 KO_Clone2_0h
- GSM9675056 KO_Clone2_0h_rep3 KO_Clone2_0h
- GSM9675057 WT_5h_rep1 WT_5h
- GSM9675058 WT_5h_rep2 WT_5h
- GSM9675059 WT_5h_rep3 WT_5h
- GSM9675060 KO_Clone1_5h_rep1 KO_Clone1_5h
- GSM9675061 KO_Clone1_5h_rep2 KO_Clone1_5h
- GSM9675062 KO_Clone1_5h_rep3 KO_Clone1_5h
- GSM9675063 KO_Clone2_5h_rep1 KO_Clone2_5h
- GSM9675064 KO_Clone2_5h_rep2 KO_Clone2_5h
- GSM9675065 KO_Clone2_5h_rep3 KO_Clone2_5h
- GSE289881 Exploring fibroblast activation protein as an early biomarker in chronic lung allograft dysfunction 10 samples shares activation, early
- GSE342301 SIRT2 deacylase modulators control B cell metabolic reprogramming in EBV infection and mitogenic activation 8 samples shares activation, control
- GSE277165 Single-cell transcriptomics and epigenomics point to CD58/CD59-CD2 interactions in controlling primary melanoma growth and immunity 20 samples shares interactions, control
- GSE274484 The Long Non-coding RNA Lnc-RAINY Regulates Genes Involved in Radiation Susceptibility Through DNA:DNA:RNA triplex-forming Interactions and has Tumor Therapeutic Potential in Non-small Cell Lung Cancers [ATAC-seq] 16 samples shares interactions, involved
- GSE285246 Spatially resolved atlas of IPF fibroblastic foci identifies that PAK2 kinase activation is involved in fibrogenesis 12 samples shares activation, involved
- GSE274680 Inflammation and lymphocyte activation during longitudinal progression to rheumatoid arthritis in at-risk individuals 243 samples shares activation
- GSE318645 Dual Immune Checkpoint Blockade Induces Distinct Systemic and Intratumoral Immune Activation in Recurrent Glioblastoma 226 samples shares activation
- GSE254732 Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects 215 samples shares activation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.